Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

Abstract Introduction Atopic dermatitis (AD) is a chronic skin disease largely driven by interleukin (IL)-13, which is targeted by tralokinumab and lebrikizumab. Effective, long-term treatments are needed, and head-to-head studies comparing these available therapeutics have yet to be conducted. This...

全面介绍

书目详细资料

Principais autores:	Matthias Augustin, April Armstrong, Naiem T. Issa, Anne Sohrt Petersen, Rie von Eyben, Teodora Festini, Tiago Torres
格式:	Artigo
语言:	Inglês
出版:	Adis, Springer Healthcare 2025-10-01
丛编:	Dermatology and Therapy
主题:	Atopic dermatitis Lebrikizumab Long-term disease management Maintenance of efficacy Matching-adjusted indirect comparison Tralokinumab
在线阅读:	https://doi.org/10.1007/s13555-025-01563-3
标签:	添加标签 没有标签, 成为第一个标记此记录!